Set to launch on October 7, the new microbiome-based skincare range Symbiome closed $15 million in funding according to WWD.

WHO: Symbiome was launched by founder and Chief Scientific Officer Larry Weiss with the intention of getting the skin’s microbiome back to its “ancestral” state. According to Weiss, the skin’s microbiome has shifted significantly since people went from hunter-gatherer mode to modern-day living. The probiotic product range is scientifically formulated using 10 ingredients or fewer.

WHY: The funding will help Symbiome continue its work in science and build out products and community.

IN THEIR OWN WORDS: “Our team identifies and targets bigger market trends that we know will reach a critical mass within the next three to 10 years,” Adam D’Augelli, partner at True Ventures, told WWD. “Larry is a science and health pioneer in the consumer goods space, coupled with Vicki’s [Chief Executive Officer Vicki Levine] d-t-c, data and business expertise, the Symbiome team’s core strengths are the exact convergence of larger market forces we were looking for in a start-up.”

DETAIL:

• Symbiome closed a $15MM funding round led by True Ventures with Bold Capital Partners, Mission Bay Capital, and Gisev Family Office and other angel investors.
• The brand will focus on direct-to-consumer sales at launch.
• Industry sources projected the brand could reach $100 million in sales by 2025 according to WWD.